Literature DB >> 20603213

The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas.

Séverine Roselli1, Yann Wallez, Lei Wang, Virginie Vervoort, Elena B Pasquale.   

Abstract

The members of the p130Cas (Cas) family are important scaffolding proteins that orchestrate cell adhesion, migration and invasiveness downstream of integrin adhesion receptors and receptor tyrosine kinases by recruiting enzymes and structural molecules. Shep1, BCAR3/AND-34 and NSP1 define a recently identified family of SH2 domain-containing proteins that constitutively bind Cas proteins through a Cdc25-type nucleotide exchange factor-like domain. To gain insight into the functional interplay between Shep1 and Cas in vivo, we have inactivated the Shep1 gene in the mouse through Cre-mediated deletion of the exon encoding the SH2 domain. Analysis of Cas tyrosine phosphorylation in the brains of newborn mice, where Shep1 is highly expressed, revealed a strong decrease in Cas substrate domain phosphorylation in knockout compared to wild-type brains. Src family kinases bind to Cas via their SH3 and SH2 domains, which contributes to their activation, and phosphorylate multiple tyrosines in the Cas substrate domain. These tyrosine-phosphorylated motifs represent docking sites for the Crk adaptor, linking Cas to the downstream Rac1 and Rap1 GTPases to regulate cell adhesion and actin cytoskeleton organization. Accordingly, we detected lower Cas-Crk association and lower phosphorylation of the Src activation loop in Shep1 knockout brains compared to wild-type. Conversely, Shep1 transfection in COS cells increases Cas tyrosine phosphorylation. The SH2 domain is likely critical for the effects of Shep1 on Cas and Src signaling because the knockout mice express Shep1 fragments that lack the amino-terminal region including the SH2 domain, presumably due to aberrant translation from internal ATG codons. These fragments retain the ability to increase Cas levels in transfected cells, similar to full-length Shep1. However, they do not affect Cas phosphorylation on their own or in the presence of co-transfected full-length Shep1. They also do not show dominant negative effects on the activity of full-length Shep1 in vivo because the heterozygous mice, which express the fragments, have a normal life span. This is in contrast to the homozygous knockout mice, most of which die soon after birth. These data demonstrate that Shep1 plays a critical role in the in vivo regulation of Src activity and Cas downstream signaling through Crk, and suggest that the SH2 domain of Shep1 is critical for these effects. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603213      PMCID: PMC2948029          DOI: 10.1016/j.cellsig.2010.06.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

1.  BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.

Authors:  A Brinkman; S van der Flier; E M Kok; L C Dorssers
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

2.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Authors:  Anurag Singh; Patricia Greninger; Daniel Rhodes; Louise Koopman; Sheila Violette; Nabeel Bardeesy; Jeff Settleman
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

3.  A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A.

Authors:  V C Dodelet; C Pazzagli; A H Zisch; C A Hauser; E B Pasquale
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 4.  Integrin signalling: a new Cas(t) of characters enters the stage.

Authors:  G M O'Neill; S J Fashena; E A Golemis
Journal:  Trends Cell Biol       Date:  2000-03       Impact factor: 20.808

5.  Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways.

Authors:  A Sakakibara; S Hattori
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 6.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

7.  BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.

Authors:  Natasha R Schuh; Michael S Guerrero; Randy S Schrecengost; Amy H Bouton
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

8.  AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.

Authors:  Anthony Makkinje; Richard I Near; Giuseppe Infusini; Pierre Vanden Borre; Alexander Bloom; Dongpo Cai; Catherine E Costello; Adam Lerner
Journal:  Cell Signal       Date:  2009-05-18       Impact factor: 4.315

9.  BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells.

Authors:  Myung-Ju Oh; Ton van Agthoven; Ji-Eun Choi; Yeon-Ji Jeong; Young-Hwa Chung; Cheol-Min Kim; Byung H Jhun
Journal:  Biochem Biophys Res Commun       Date:  2008-08-21       Impact factor: 3.575

10.  Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens.

Authors:  Richard I Near; Richard S Smith; Paul A Toselli; Thomas F Freddo; Alexander B Bloom; Pierre Vanden Borre; David C Seldin; Adam Lerner
Journal:  Mol Vis       Date:  2009-04-03       Impact factor: 2.367

View more
  9 in total

1.  SHEP1 partners with CasL to promote marginal zone B-cell maturation.

Authors:  Cecille D Browne; Melanie M Hoefer; Suresh K Chintalapati; Matthew H Cato; Yann Wallez; Derek V Ostertag; Elena B Pasquale; Robert C Rickert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

2.  Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1.

Authors:  Olivier Herbin; Adam G Regelmann; Bhama Ramkhelawon; Erica G Weinstein; Kathryn J Moore; Konstantina Alexandropoulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

Review 3.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

4.  The SRC homology 2 domain protein Shep1 plays an important role in the penetration of olfactory sensory axons into the forebrain.

Authors:  Lei Wang; Virginie Vervoort; Yann Wallez; Nathalie Coré; Harold Cremer; Elena B Pasquale
Journal:  J Neurosci       Date:  2010-09-29       Impact factor: 6.167

5.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

6.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

7.  NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.

Authors:  Peter D Mace; Yann Wallez; Małgorzata K Dobaczewska; Jeongeun J Lee; Howard Robinson; Elena B Pasquale; Stefan J Riedl
Journal:  Nat Struct Mol Biol       Date:  2011-11-13       Impact factor: 15.369

8.  A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics.

Authors:  Jason D Berndt; Carissa Pilling; Elizabeth M Steenkiste; Christopher Simpkins; Jonathan A Cooper
Journal:  Elife       Date:  2021-06-25       Impact factor: 8.140

9.  Profiling, Bioinformatic, and Functional Data on the Developing Olfactory/GnRH System Reveal Cellular and Molecular Pathways Essential for This Process and Potentially Relevant for the Kallmann Syndrome.

Authors:  Giulia Garaffo; Paolo Provero; Ivan Molineris; Patrizia Pinciroli; Clelia Peano; Cristina Battaglia; Daniela Tomaiuolo; Talya Etzion; Yoav Gothilf; Massimo Santoro; Giorgio R Merlo
Journal:  Front Endocrinol (Lausanne)       Date:  2013-12-31       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.